logo

A Light-based technologies for management of COVID-19 pandemic

PDF Publication Title:

A Light-based technologies for management of COVID-19 pandemic ( a-light-based-technologies-management-covid-19-pandemic )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 006

C.P. Sabino, et al. Journal of Photochemistry & Photobiology, B: Biology 212 (2020) 111999 surfaces as well as potential therapeutic applications that can reduce COVID-19 morbidity and mortality. From our perspective, light pro- vides several practical answers to the new logistical and therapeutic challenges brought by COVID-19. Therefore, we suggest that the death toll and quarantine extent can be significantly mitigated if at least part of these strategies are encouraged and implemented by health systems. Given the urgent demand raised by the current uncontrolled pandemic we must be ready to use all the available armamentarium to fight COVID-19. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influ- ence the work reported in this paper. We attest no conflict of interest in the manuscript we are submitting entitled “Antimicrobial light-based technologies for management of COVID-19 pandemic crisis”. Acknowledgements CPS was supported by the São Paulo Research Foundation (FAPESP, grant 2017/22406-0) and by the Brazilian National Council for Scientific and Technological Development (CNPq, scholarship 141901/ 2016-0). FPS is supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES Finance code 001). ALS is supported by a Marie-Curie Global Fellowship mentored by GPT (EU project 843116 – REBELLION). TD is supported by USA National Institutes of Health (NIH, grant R01AI123312) and by the Department of Defense (DoD, grant FA9550-17-1-0277). MRH is supported by USA National Institutes of Health (NIH, grants R01AI050875 and R21AI121700). MSR thanks Photonics Institute (INCT/CNPq, grant 465763/2014-6) for financial support. MSB acknowledges FAPESP for the CEPID Redoxoma grant 2013/07937-8. References [1] N. Zhu, D. Zhang, W. Wang, et al., A Novel Coronavirus from Patients with Pneumonia in China, 2019, N. Engl. J. Med. 382 (8) (2020) 727–733. [2] C. Huang, Y. Wang, X. Li, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 395 (10223) (2020) 497–506. [3] J. Bedford, D. Enria, J. Giesecke, et al., COVID-19: towards controlling of a pan- demic, Lancet 395 (10229) (2020) 1015–1018. [4] C.R. Wells, P. Sah, S.M. Moghadas, et al., Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak, Proc. Natl. Acad. Sci. U. S. A. 117 (13) (2020) 7504–7509. [5] B. Xu, M.U.G. Kraemer, Group OC-DC, Open access epidemiological data from the COVID-19 outbreak, Lancet Infect. Dis. 20 (5) (2020) 534. [6] C. Sohrabi, Z. Alsafi, N. O’Neill, et al., World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19), Int. J. Surg. 76 (2020) 71–76. [7] M. Lipsitch, D.L. Swerdlow, L. Finelli, Defining the Epidemiology of Covid-19 - Studies Needed, N. Engl. J. Med. (2020), https://doi.org/10.1056/ NEJMp2002125. [8] F. Zhou, T. Yu, R. Du, et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet 395 (10229) (2020) 1054–1062. [9] L. D’Antiga, Coronaviruses and immunosuppressed patients. The facts during the third epidemic, Liver Transpl. 26 (6) (2020) 832–834. [10] Z. Wu, J.M. McGoogan, Characteristics of and important lessons from the cor- onavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention, JAMA 323 (13) (2020) 1239–1242. [11] C.N. Wu, L.Z. Xia, K.H. Li, et al., High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a pro- spective randomised controlled trial, Br. J. Anaesth. 125 (1) (2020) e166–e168. [12] T.P. Velavan, C.G. Meyer, The COVID-19 epidemic, Tropical Med. Int. Health 25 (3) (2020) 278–280. [13] G. Grasselli, A. Pesenti, M. Cecconi, Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response, JAMA (2020), https://doi.org/10.1001/jama.2020.4031. [14] Lancet, T. COVID-19: protecting health-care workers, Lancet 395 (2020) 922. [15] Y. Liu, R.M. Eggo, A.J. Kucharski, Secondary attack rate and superspreading events for SARS-CoV-2, Lancet 395 (2020) e47. [16] N. van Doremalen, T. Bushmaker, D.H. Morris, et al., Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N. Engl. J. Med. 382 (2020) 1564–1567. [17] G. Kampf, D. Todt, S. Pfaender, E. Steinmann, Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents, J Hosp Infect 104 (2020) 246–251. [18] Duclaux, Comptes rendus des séances de la Société de biologie et de ses filiales, (1885), p. 395. [19] A. Downes, T. Blunt, The influence of light upon the development of bacteria, Nature 16 (218) (1877). [20] T. Rivers, F.L. Gates, Ultra-Violet Light and Vaccine Virus: II. The effect of monocheomatic Ultra-Violet light upon vaccine virus, J. Exp. Med. 47 (1928) 45–49. [21] N. Finsen, Phototherapy, Edward Arnold, London, 1901. [22] R. Ackroyd, C. Kelty, N. Brown, M. Reed, The history of photodetection and photodynamic therapy, Photochem. Photobiol. 74 (5) (2001) 656–669. [23] P. Brickner, R.L. Vincent, Ultraviolet germicidal irradiation safety concerns: a lesson from the Tuberculosis Ultraviolet Shelter Study: Murphy’s Law affirmed, Photochem. Photobiol. 89 (2013) 819–821. [24] T. St Denis, T. Dai, L. Izikson, et al., All you need is light: antimicrobial photo- inactivation as an evolving and emerging discovery strategy against infectious disease, Virulence 2 (2011) 509–520. [25] T. Dai, The antimicrobial effect of blue light: What are behind? Virulence 8 (6) (2017) 649–652. [26] Y. Qiu, Q. Li, B.E. Lee, et al., UV inactivation of human infectious viruses at two full-scale wastewater treatment plants in Canada, Water Res. 147 (2018) 73–81. [27] A. Ben-David, J.L. Sagripanti, A model for inactivation of microbes suspended in the atmosphere by solar ultraviolet radiation, Photochem. Photobiol. 86 (2010) 895–908. [28] A.K. Abhimanyu Coussens, The role of UV radiation and vitamin D in the sea- sonality and outcomes of infectious disease, Photochem Photobiol Sci 16 (2017) 314–338. [29] W.B. Grant, H. Lahore, S.L. McDonnell, et al., Vitamin D supplementation could prevent and treat influenza, coronavirus, and pneumonia infections, Preprints (2020), https://doi.org/10.20944/preprints202003.0235.v1. [30] S.E. Beck, R.A. Rodriguez, M.A. Hawkins, T.M. Hargy, T.C. Larason, K.G. Linden, Comparison of UV-Induced Inactivation and RNA Damage in MS2 Phage across the Germicidal UV Spectrum, Appl. Environ. Microbiol. 82 (5) (2015) 1468–1474. [31] IUVA, Fact Sheet on UV Disinfection for COVID-19, LEDs Magazine (2020), https://www.ledsmagazine.com/company-newsfeed/article/14172974/iuva- releases-a-fact-sheet-on-covid19-and-uvcband-disinfection. [32] W. Kowalski, T.J. Walsh, V. Petraitis, COVID-19 Coronavirus Ultraviolet Susceptibility. 2020, Available at, 2020. https://www.researchgate.net/ publication/339887436_2020_COVID-19_Coronavirus_Ultraviolet_Susceptibility. [33] M. Darnell, K. Subbarao, S.M. Feinstone, D.R. Taylor, Inactivation of the cor- onavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 121 (2004) 85–91. [34] C.M. Walker, G. Ko, Effect of ultraviolet germicidal irradiation on viral aerosols, Environ Sci Technol 41 (15) (2007) 5460–5465. [35] W.S. Jordan, The mechanism of spread of Asian influenza, Am Rev Respir Dis 83 (2) (1961) 29–40 Pt 2. [36] J. McDevitt, S.N. Rudnick, L.J. Radonovich, Aerosol susceptibility of influenza virus to UV-C light, Appl. Environ. Microbiol. 78 (2012) 1666–1669. [37] C. Tseng, C.S. Li, Inactivation of viruses on surfaces by ultraviolet germicidal ir- radiation, J. Occup. Environ. Hyg. 4 (2007) 400–495. [38] R.J. Fischer, D.H. Morris, N. van Doremalen, et al., Assessment of N95 respirator decontamination and re-use for SARS-CoV-2, medRxiv (2020), https://doi.org/10. 1101/2020.04.11.20062018. [39] J. Kyle, K. Card, D. Dena Crozier, et al., UV sterilization of personal protective equipment with idle laboratory biosafety cabinets during the Covid-19 pandemic, (2020) Available at https://www.medrxiv.org/content/10.1101/2020.03.25. 20043489v2. [40] N95DECON, Technical report for UV-C-based N95 reuse risk management, (2020) Available at: https://static1.squarespace.com/static/ 5e8126f89327941b9453eeef/t/5e8541760211467623b1e4e4/1585791351199/ 200401_N95DECON_UV_technicalreport_v1.2_final.pdf. [41] L. Lilge, A. Manalac, M. Weersink, et al., Light propagation within N95 Filtered Face Respirators: A simulation study for UVC decontamination, (2020) Available at https://www.medrxiv.org/content/10.1101/2020.06.12.20129395v2. [42] W. Lindsley, S.B. Martin Jr., R.E. Thewlis, et al., Effects of Ultraviolet Germicidal Irradiation (UVGI) on N95 Respirator Filtration Performance and Structural Integrity, J. Occup. Environ. Hyg. 12 (2015) 509–517. [43] K. O’Hearn, S. Gertsman, M. Sampson, et al., Decontaminating N95 masks with ultraviolet germicidal irradiation (UVGI) does not impair mask efficacy and safety: A Systematic Review, J Hosp Inf (2020), https://doi.org/10.1016/j.jhin.2020.07. 014. [44] K. Song, F. Taghipour, M. Mohseni, Microorganisms inactivation by wavelength combinations of ultraviolet light-emitting diodes (UV-LEDs), Sci. Total Environ. 665 (2019) 1103–1110. [45] S. Beck, H. Ryu, L.A. Boczek, et al., Evaluating UV-C LED disinfection performance and investigating potential dual-wavelength synergy, Water Res. 109 (2017) 207–216. [46] D. Welch, M. Buonanno, V. Grilj, et al., Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases, Sci Rep 8 (2018) 2752. [47] A. Teles, T.M.A. Oliveira, F.C. Bezerra, et al., Photodynamic inactivation of Bovine herpesvirus type 1 (BoHV-1) by porphyrins, J Gen Virol 99 (2018) 1301–1306. 6

PDF Image | A Light-based technologies for management of COVID-19 pandemic

a-light-based-technologies-management-covid-19-pandemic-006

PDF Search Title:

A Light-based technologies for management of COVID-19 pandemic

Original File Name Searched:

light-based-covid-pandemic-management.pdf

DIY PDF Search: Google It | Yahoo | Bing

Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info

Cruising Review Topics and Articles More Info

Software based on Filemaker for the travel industry More Info

The Burgenstock Resort: Reviews on CruisingReview website... More Info

Resort Reviews: World Class resorts... More Info

The Riffelalp Resort: Reviews on CruisingReview website... More Info

CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com | RSS | AMP